A Review of Sudden Cardiac Death in Young Athletes and Strategies for Preparticipation Cardiovascular Screening

Journal of Athletic Training

Volumn 36, Issue 2, 2001, Pages 197-204

  Koester, Michael C ^a,b  

^a Good Shepherd Medical Center   (United States)

^b NONE   (United States)

Author keywords

Coronary artery anomalies; Hypertrophic cardiomyopathy; Preparticipation athletic evaluation; Sudden cardiac death

Indexed keywords

EID: 0347608536     PISSN: 10626050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Maron BJ. Sudden death in young athletes: lessons from the Hank Gathers affair. N Engl J Med. 1993;329:55-57.
2. Mitten MJ, Maron BJ. Legal considerations that affect medical eligibility for competitive athletes with cardiovascular abnormalities and acceptance of Bethesda Conference recommendations. J Am Coll Cardiol. 1994;24: 861-863.
3. Hudson MA. A legacy on court, in court. Los Angeles Times. October 6, 1992:A1.
4. Fainaru S, Foreman J, Golden D, MacMullan J, Manly H, Kurkjian S. The death of Reggie Lewis: a search for answers. Boston Globe. September 12, 1993:70-76.
5. Van Camp S. What can we learn from Reggie Lewis' death? Physician Sportsmed. 1993;21(10):73-87.
6. Thompson PD. Athletes, athletics, and sudden cardiac death. Med Sci Sports Exerc. 1993;25:981-984.
7. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA. 1996;276:199-204.
8. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995;27:641-647.
9. Maron MJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes: a statement for health professionals from the Sudden Death Committee and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation. 1996;94:850-856.
10. Koester MC. Refocusing the adolescent preparticipation physical evaluation toward preventive health care. J Athl Train. 1995;30:352-360.
11. Lombardo JA, Robinson JB, Smith DM. Preparticipation Physical Evaluation. Kansas City, MO: American Academy of Family Physicians, American Academy of Pediatricians, American Medical Society for Sports Medicine, American Orthopedic Society for Sports Medicine, American Osteopathic Academy of Sports Medicine; 1992.
12. Smith DM, Kovan JR, Rich BSE, Tanner SM. Preparticipation Physical Evaluation. 2nd ed. Minneapolis, MN: McGraw-Hill Inc; 1997.
13. Hergenroeder AC. The preparticipation sports examination. Pediatr Clin North Am. 1997;44:1525-1540.
14. Smith DM. Pre-participation physical evaluations: development of uniform guidelines. Sports Med. 1994;18:293-300.
15. Rich BS. Sudden death screening. Med Clin North Am. 1994;78:267-288.
16. Maron BJ. Cardiovascular risks to young persons on the athletic field. Ann Intern Med. 1998;129:379-386.
17. Myerburg RJ. Sudden death. J Continuing Educ Cardiol. 1978;13:15-29.
18. Van Camp SP. Sudden death. Clin Sports Med. 1992;11:273-289.
19. Phillips M, Robinowitz M, Higgins JR, Boran KJ, Reed T, Virmani R. Sudden cardiac death in Air Force recruits: a 20-year review. JAMA. 1986;256:2696-2699.
20. Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol. 1998;32:1881-1884.
21. Ragosta M, Crabtree J, Sturner WQ, Thompson PD. Death during recreational exercise in the State of Rhode Island. Med Sci Sports Exerc. 1984;16:339-342.
22. Futterman LG, Myerburg R. Sudden death in athletes: an update. Sports Med. 1998;26:335-350.
23. Wight JN Jr, Salem D. Sudden cardiac death and the "athlete's heart" Arch Intern Med. 1995;155:1473-1480.
24. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation. 1995;91:1596-1601.
25. McCaffrey FM, Braden DS, Strong WB: Sudden cardiac death in young athletes: a review. Am J Dis Child. 1991;145:177-183.
26. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation. 1982;65:1388-1394.
27. Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE. Sudden death in young athletes. Circulation. 1980;62:218-229.
28. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild D. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785-789.
29. Maron BJ, Roberts WC. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation. 1979;59:689-706.
30. Reisdorff EJ, Prodinger RJ. Sudden cardiac death in the athlete. Emerg Med Clin North Am. 1998;16:281-294.
31. Cheitlin MD, De Castro CM, McAllister HA. Sudden death as a complication of anomalous left coronary origin from the anterior sinus of Valsalva: a not-so-minor congenital anomaly. Circulation. 1974;50:780-787.
32. Thiene G, Basso C, Corrado D. Is prevention of sudden death in young athletes feasible? Cardiologia. 1999;44:497-505.
33. Liberthson RR, Dinsmore RE, Fallon JT. Aberrant coronary artery origin from the aorta: report of 18 patients, review of literature and delineation of natural history and management. Circulation. 1979;59:748-754.
34. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000; 35:1493-1501.
35. Bresler MJ. Acute pericarditis and myocarditis. Emerg Med. 1992;24:35-51.
36. Lecomte D, Fornes P, Fouret P, Nicholas G. Isolated myocardial fibrosis as a cause of sudden cardiac death and its possible relation to myocarditis. J Forensic Sci. 1993;38:617-621.
37. McKeag DB. Preparticipation screening of the potential athlete. Clin Sports Med. 1989;8:373-397.
38. Ackerman MJ. The long QT syndrome. Pediatr Rev. 1998;19:232-238.
39. Estes NA III. Sudden death in young athletes. N Engl J Med. 1995;333: 337-341.
40. Maron BJ, Poliac LC, Kaplan JA, Mueller FO. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med. 1995;333:337-342.
41. Furlanello F, Bettini R, Cozzi F, et al. Ventricular arrhythmias and sudden death in athletes. Ann N Y Acad Sci. 1984;427:253-279.
42. O'Connor FG, Kugler JP, Oriscello RG. Sudden death in young athletes: screening for the needle in the haystack. Am Fam Physician. 1998;57: 2763-2770.
43. Zehender M, Meinertz T, Keul J, Just H. ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J. 1990;119:1378-1391.
44. Magnes SA, Henderson JM, Hunter SC. What conditions limit sports participation? Experience with 10,540 athletes. Physician Sportsmed. 1992;20(5):143-160.
45. Smith J, Laskowski ER. The preparticipation physical examination: Mayo Clinic experience with 2,739 examinations. Mayo Clin Proc. 1998;73: 419-429.
46. Weidenbener EJ, Krauss MD, Waller BF, Taliercio CP. Incorporation of screening echocardiography in the preparticipation exam. Clin J Sport Med. 1995;5:86-89.
47. Maron BJ, Bodison SA, Wesley YE, Tucker E, Green KJ. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol. 1987;10:1214-1221.
48. Murry PM, Cantwell JD, Heath DL, Shoop J. The role of limited echocardiography in screening athletes. Am J Cardiol. 1995;76:849-850.
49. Lewis JF, Maron BJ, Diggs JA, Spencer JE, Mehrotra PP, Curry CL. Preparticipation echocardiographic screening for cardiovascular disease in a large, predominantly black population of collegiate athletes. Am J Cardiol. 1989;64:1029-1033.
50. Fuller CM, McNulty CM, Spring DA, et al. Prospective screening of 5,615 high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc. 1997;29:1131-1138.
51. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364-369.
52. Ades PA. Preventing sudden death. Physician Sportsmed. 1992;20(9):75-89.
53. Bergman AB, Stamm SJ. The morbidity of cardiac nondisease in school-children. N Engl J Med. 1967;276:1008-1013.
54. Maron BJ, Wesley YE, Arce J. Hypertrophic cardiomyopathy compatible with successful completion of the marathon. Am J Cardiol. 1984;53: 1470-1471.
55. Simons SM, Moriarity J. Hypertrophic cardiomyopathy in a college athlete. Med Sci Sports Exerc. 1992;24:1321-1324.
56. Maron BJ, Isner JM, McKenna WJ. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. J Am Coll Cardiol. 1994;24:880-885.
57. Knapp v Northwestern University, 101F 3d 473 (7th Cir 1996).
58. Pfister GC, Puffer JC, Maron BJ. Preparticipation cardiovascular screening for US collegiate student-athletes. JAMA. 2000;283:1597-1599.
59. Gomez JE, Lantry BR, Saathoff KNS. Current use of adequate preparticipation history forms for heart disease screening of high school athletes. Arch Pediatr Adolesc Med. 1999;153:723-726.
60. Glover DW, Maron BJ. Profile of preparticipation cardiovascular screening for high school athletes. JAMA. 1998;279:1817-1819.
61. Oregon Schools Activities Association. Minutes of spring 1999 meeting. Available at: http://www.osaa.org/events/meet#May3,1999. Accessed May 5, 2000.